Unexpectedly, PBMCs from TBM patients showed reduced inflammatory and TNF signaling, but enhanced IFN-α/γ responses, in several subsets of T and NK cells compared with healthy controls (Fig. 4D). This evidence concerns the gene IFNA1 and meningeal tuberculosis.